carismatx.com (CARM) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Carisma Therapeutics (CARM) CAR-makrofaglarga bo'lgan noelastik talab tufayli sezilarli bozor ta'siriga ega. Uzoq muddatli qarz va kapital strukturasi moliyaviy barqarorlikni tasdiqlaydi, bunda 0.00 ushbu parametrning miqdorini aks ettiradi. Ko'krak va o'pka qattiq o'smalariga qarshi kurashishning innovatsion usullari noyob ustunlik yaratadi. Shu bilan birga, biznes makroiqtisodiy tebranishlarni e'tiborsiz qoldirib, buning o'rniga klinik sinovlar natijalariga tayanadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_CARM_-_Carisma-Therapeutics_-_Long-Term-Debt-to-Capital "CARM: Carisma Tx Uzoq muddatli qarzning kapitalga nisbati 28.04.2023 - 25.10.2025 | 👁️GURU.Markets👁️")
Carisma Therapeutics Inc (CARM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Carisma Therapeutics|CARM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Carisma Tx|CARM - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Carisma Therapeutics Inc.|CARM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Carisma Therapeutics|Tezkor likvidlik ko‘rsatkichi carismatx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:carismatx.com - CARM
ESG standartlariga muvofiq axloqiy saraton immunoterapiyasini ishlab chiqish biolaboratoriyalarga sezilarli kapital xarajatlarini talab qiladi. Uzoq muddatli kreditlarning kapitalga nisbati Carisma Therapeutics (CARM) kompaniyasining muddati bir yildan ortiq bo'lgan tashqi moliyalashtirishga bog'liqligini o'lchaydi. 0.00 ning joriy qiymati aksiyadorlar qiymatiga nisbatan qarz yuklamasi darajasini ko'rsatadi. Ushbu ko'rsatkichning tendentsiyasi kredit riski va investitsiya faoliyati o'rtasidagi muvozanatni aks ettiradi. Investorlar ushbu metrikani biznesning moliyaviy barqarorligi ko'rsatkichi sifatida baholaydilar.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|Pieris Corp (PVLA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SVRA: Uzoq muddatli qarzning kapitalga nisbati|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|ATXS: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ENGN|Uzoq muddatli qarzdorlikning kapitalga nisbati rapt.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Aerovate Therapeutics JBIO|Uzoq muddatli qarzdorlikning kapitalga nisbati aclaristx.com (ACRS)|KYTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Tiziana Life Sciences Ltd. (TLSA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA: Uzoq muddatli qarzning kapitalga nisbati|Ventyx Biosciences, Inc (VTYX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati THTX|AVTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ELDN (Eledon Pharmaceuticals, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati AGEN|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ZURA|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Adagene|ikenaoncology.com (IMA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Shattuck Labs - Uzoq muddatli qarzning kapitalga koeffitsiyenti|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Connect Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunic, Inc. (IMUX)|ATRA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|X4 Pharmaceuticals Inc. (XFOR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ACET: Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU - Uzoq muddatli qarzning kapitalga nisbati|INMB (INmune Bio, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BRNS: Uzoq muddatli kreditlarning kapitalga nisbati|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|SAB Biotherapeutics Inc. (SABS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AKTX|Uzoq muddatli qarzning o'z kapitaliga nisbati enlivex.com ENLV|Uzoq muddatli qarzning o'z kapitaliga nisbati Q32 Bio QTTB|Uzoq muddatli qarzdorlikning kapitalga nisbati geovax.com (GOVX)|Edesa Biotech - Uzoq muddatli qarzning kapitalga nisbati|iBio Inc (IBIO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Bolt Biotherapeutics, Inc. (BOLT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|APVO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|Uzoq muddatli qarzning o'z kapitaliga nisbati aditxt.com ADTX|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX (XORTX Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati